Aramchol Enhances Regorafenib Efficacy in Treating Gastrointestinal Tumors
A groundbreaking study published in the latest volume of Oncotarget reveals a promising therapeutic synergy between aramchol, an emerging SCD1 ...
Tag: metabolic vulnerability targeting
